FDA Adverse Event Injury Summary report: N

WILLOW WEARABLE BREAST PUMP

MDR report key: 10618204 · Received October 1, 2020

Report

Report Number
3012759464-2020-00013
Event Type
Injury
Date Received
October 1, 2020
Date of Event
June 15, 2020
Report Date
October 1, 2020
Manufacturer
EXPLORAMED NC7, INC.
Product Code
HGX
UDI-DI
00858298006446
PMA / PMN Number
K191577
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER REPORTED THRUSH WHICH WAS TREATED BY A DOCTOR PRESCRIBED ANTIFUNGAL MEDICATION. THRUSH IS CAUSED BY A YEAST FUNGUS. YEAST GROWS IN MOIST, WARM ENVIRONMENTS. RISK OF DEVELOPING THRUSH CAN BE INCREASED BY RECENT COURSE OF ANTIBIOTICS1, CRACKED OR DAMAGED NIPPLES1, ORAL CONTRACEPTIVES OR STEROIDS 1, CLOTHING NOT DESIGNED FOR BREASTFEEDING THAT TRAPS MOISTURE2, AND HOT, HUMID CONDITIONS. THE WILLOW DEVICE WAS NOT RETURNED TO EXPLORAMED NC7 FOR EVALUATION. HOWEVER, A MANUFACTURING REVIEW WAS CONDUCTED ON THE DEVICE HISTORY RECORD AND NO NONCONFORMANCES WERE NOTED IN THE PRODUCTION OF THIS DEVICE. BASED ON THE INFORMATION PROVIDED, IT CANNOT BE DEFINITIVELY CONCLUDED THAT THE WILLOW BREAST PUMP CAUSED OR CONTRIBUTED TO THIS INCIDENT OF THRUSH. LA LECHE LEAGUE INTERNATIONAL, HTTPS://WWW.LLLI.ORG/BREASTFEEDING-INFO/THRUSH/. HEALTHLINE, NIPPLE THRUSH AND BREASTFEEDING, HTTPS://WWW.HEALTHLINE.COM/HEALTH/NIPPLE-THRUSH#TAKEAWAY.

Description of Event or Problem · 1

THE CUSTOMER REPORTED TO WILLOW CUSTOMER CARE ON (B)(6) 2020 THAT SHE EXPERIENCED THRUSH INFECTION WHICH BEGAN MID TO END OF (B)(6) (CUSTOMER UNSURE OF EXACT DATE) AND WAS TREATED BY A PRESCRIBED ANTIFUNGAL, DIFLUCAN, STARTING ON (B)(6) 2020. CUSTOMER CONTINUED PUMPING WITH AN ALTERNATIVE PUMP THROUGHOUT TREATMENT. CUSTOMER REPORTED THAT HER THRUSH INFECTION HAS RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1076378 WILLOW WEARABLE BREAST PUMP POWERED BREAST PUMP HGX EXPLORAMED NC7, INC. PDW48 00858298006446

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention